These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 22394063
1. Optimal production of L-threo-2,3-dihydroxyphenylserine (L-threo-DOPS) on a large scale by diastereoselectivity-enhanced variant of L-threonine aldolase expressed in Escherichia coli. Gwon HJ, Yoshioka H, Song NE, Kim JH, Song YR, Jeong DY, Baik SH. Prep Biochem Biotechnol; 2012; 42(2):143-54. PubMed ID: 22394063 [Abstract] [Full Text] [Related]
4. Synthesis of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) with thermostabilized low-specific L-threonine aldolase from Streptomyces coelicolor A3(2). Balk SH, Yoshioka H, Yukawa H, Harayama S. J Microbiol Biotechnol; 2007 May; 17(5):721-7. PubMed ID: 18051291 [Abstract] [Full Text] [Related]
5. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys]. Fujiwara H, Inagaki C, Ikeda Y, Tanaka C. Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060 [Abstract] [Full Text] [Related]
6. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients. Maruyama W, Naoi M, Narabayashi H. J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986 [Abstract] [Full Text] [Related]
9. A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis. Maruyama W, Nakahara D, Naoi M. J Neural Transm Park Dis Dement Sect; 1994 Jul; 7(1):21-33. PubMed ID: 8579767 [Abstract] [Full Text] [Related]
10. L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease. Ogawa N, Yamamoto M, Takayama H. J Med; 1985 Jul; 16(5-6):525-34. PubMed ID: 3938472 [Abstract] [Full Text] [Related]
19. Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy. Suzuki T, Higa S, Sakoda S, Ueji M, Hayashi A, Takaba Y, Nakajima A. Eur J Clin Pharmacol; 1982 Jul; 23(5):463-8. PubMed ID: 6818040 [Abstract] [Full Text] [Related]
20. Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations. Yamamoto M, Ujike H, Ogawa N. Clin Neuropharmacol; 1985 Jul; 8(4):334-42. PubMed ID: 2416437 [Abstract] [Full Text] [Related] Page: [Next] [New Search]